SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-037045
Filing Date
2017-06-01
Accepted
2017-06-01 20:49:21
Documents
1
Period of Report
2017-05-30

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5395
  Complete submission text file 0001104659-17-037045.txt   6739
Mailing Address C/O DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN NJ 07960
Business Address
Talbot George Harrison (Reporting) CIK: 0001554194 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 17886226

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Issuer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations